Sector Update: Health Care Stocks Lower Friday Afternoon
Health care stocks were retreating Friday afternoon, with the NYSE Health Care Index falling 1.5% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.6%. The iShares Biotechnology ETF (IBB) w
MT NewswiresApr 12 13:48 ET
Theravance Biopharma Shares Rise After BTIG Starts Coverage at Buy
Theravance Biopharma (TBPH) shares climbed 8.3% in recent Friday trading after BTIG started its coverage with a buy rating and a price target of $21. Trading volume stood at more than 330,000 shares a
MT NewswiresApr 12 12:41 ET
Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers
Seeking AlphaApr 12 10:00 ET
Express News | BTIG Initiates Coverage On Theravance Biopharma With Buy Rating, Announces Price Target of $21
Moomoo 24/7Apr 12 07:42 ET
Theravance Biopharma Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 135.16% BTIG → $21 Initiates Coverage On → Buy 08/08/2023 123.96% HC Wainwright & Co. → $20 Rei
BenzingaApr 12 07:36 ET
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (NOH) in Patients With Multiple System Atrophy (MSA) on May 23, 2024
Theravance Biopharma, Inc. (the "Company") (NASDAQ: TBPH) today announced it will host a virtual KOL event on Thursday, May 23, 2024 from 10:00 AM to ...
PR NewswireApr 10 06:00 ET
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Yahoo FinanceApr 3 11:30 ET
A New Cause for Concern: Theravance Biopharma Adds a New Costs Risk
TipRanksMar 3 01:00 ET
Theravance Biopharma: A Strong Buy on Underappreciated Cash Flow Potential and Strategic Milestones
TipRanksFeb 27 23:39 ET
Earnings Call Summary | Theravance Biopharma(TBPH.US) Q4 2023 Earnings Conference
The following is a summary of the Theravance Biopharma, Inc. (TBPH) Q4 2023 Earnings Call Transcript:Financial Performance:YUPELRI's net sales growth for the full year of 2023 was 9%, achieving $221 m
moomoo AIFeb 26 22:09 ET · Conference Call
Balancing Growth Prospects and Clinical Outcomes: Hold Rating on Theravance Biopharma
TipRanksFeb 26 21:55 ET
Theravance Biopharma Expects Non-GAAP Loss In H1 Of 2024 And Approach Non-GAAP Breakeven In H2 Of 2024; Limited Cash Burn Expected In 2024
Theravance Biopharma Expects Non-GAAP Loss In H1 Of 2024 And Approach Non-GAAP Breakeven In H2 Of 2024; Limited Cash Burn Expected In 2024
BenzingaFeb 26 16:27 ET
Recap: Theravance Biopharma Q4 Earnings
Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsTheravance Biopharma miss
BenzingaFeb 26 16:10 ET
Express News | Theravance Biopharma Q4 2023 GAAP EPS $(0.17) Misses $(0.15) Estimate, Sales $17.57M Miss $17.68M Estimate
Moomoo 24/7Feb 26 16:08 ET
Theravance Biopharma 4Q Rev $17.6M >TBPH
Theravance Biopharma 4Q Rev $17.6M >TBPH
Dow JonesFeb 26 16:05 ET
Press Release: Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update PR Newswire DUBLIN, Feb. 26, 2024 -- Q4 2023 YUPELRI(R) (revefenacin) net sale
Dow JonesFeb 26 16:05 ET
Earnings Scheduled For February 26, 2024
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.23 per share on revenue of $477.73 million. • Krystal Biotech (NASDAQ:KRYS) is estimated
BenzingaFeb 26 04:47 ET
Notable Earnings After Monday's Close
Seeking AlphaFeb 25 17:35 ET
Theravance Biopharma Q4 2023 Earnings Preview
Seeking AlphaFeb 25 17:35 ET
A Preview Of Theravance Biopharma's Earnings
Theravance Biopharma (NASDAQ:TBPH) is set to give its latest quarterly earnings report on Monday, 2024-02-26. Here's what investors need to know before the announcement.Analysts estimate that Theravan
BenzingaFeb 23 12:01 ET
No Data
No Data